This course is FREE with Unlimited CE!

Choose from two Unlimited CE subscription options and get access to 600+ CE and professional development courses.

Goals and Learning Outcomes

Total joint replacement or arthroplasty is one of the most dependable and safest procedures today (Crow, 2020). Patients who undergo a hip or knee arthroplasty are likely to enjoy their new joint for 20 years or more. The American Joint Replacement Registry’s annual report in 2021 indicated that despite the COVID-19 pandemic, data from a total of 2,244,587 hip and knee procedures had been collected, indicating a procedural volume increase of over 18% when compared to the annual report of 2020 (American Academy of Orthopaedic Surgeons [AAOS], 2021a). By understanding the basis of the arthritic changes that damage joints, recognizing indications for total joint arthroplasty, and reviewing the surgical procedures and possible complications of joint replacement surgery, nurses can provide more competent care.

 

The goal of this course is to equip nurses in the acute care setting with knowledge of indications for total hip and knee replacements, surgical procedures used for these procedures, and pre-op and post-op nursing care of patients undergoing hip or knee replacements.


After taking this course, you should be able to:

  • Identify interventions that healthcare professionals, as a team, can use to prevent complications after joint replacement surgery
  • Describe two strategies to help patients and families cope with self-care deficits, and the transition from hospital to home after a total joint replacement
  • Discuss the impact of managed care on preventing complications and supervising care for people who have had joint replacement surgery
  • Identify indications for total joint replacements
  • Recall surgical procedures for hip and knee replacements
  • Recognize the common complications and evidence-based nursing care for patients undergoing total hip and knee replacements

Course Termination Date: Not yet determined

Content Expiration Date: 12/31/25

Course Originally Released On: 10/01/22

Course Authors

4.4 Average

Course Reviews

14433 reviews

Accreditation Information

NURSES

In support of improving patient care, Relias LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Provider approved by the California Board of Registered Nursing, CEP#13791

Disclaimer: Not all courses will provide California Board of Registered Nursing approval. Per California Assembly Bill No. 241, continuing education courses related to direct patient care shall address at least one or a combination of the following:(1) Examples of how implicit bias affects perceptions and treatment decisions of licensees, leading to disparities in health outcomes; or (2) Strategies to address how unintended biases in decision-making may contribute to health care disparities by shaping behavior and producing differences in medical treatment along lines of race, ethnicity, gender identity, sexual orientation, age, socioeconomic status, or other characteristics.

 

CEBroker

Relias LLC reports to CEBroker for the following boards (Provider # 50-1489): Arkansas State Board Of Nursing, District Of Columbia Board Of Nursing, Florida Board Of Nursing, Georgia Board Of Nursing, Kansas State Board of Nursing, Kentucky Board of Nursing, Michigan Board of Nursing, Mississippi Board of Nursing, New Hampshire Board of Nursing, New Mexico Board Of Nursing, North Dakota Board of Nursing, South Carolina Board Of Nursing and West Virginia Board Of Registered Nurses

 

Please check the licenses/certifications section under my account (after logging in) to make sure you have entered a valid license number. This information is required for correct reporting of your course completions to CE Broker.

 

Disclosures

None of the planners/faculty, unless otherwise noted, for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.